MSCs protect tumor cells against spontaneous and drug-induced apoptosis by activating BCR and changing the expression of antiapoptotic molecules, SDF-1, and vascular endothelial growth factor (VEGF) [10,15]. The gene discussed is BCR; the disease is neoplasm.